Michael Derndorfer

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

Luigi Di Biase, Dhanujaya Lakkireddy, Chintan Trivedi et al. · Heart Rhythm · 2015 · 158 citations

Thrombosis, Cardiac Anaesthesia, Patient Safety +10

Asymptomatic cerebral lesions during pulmonary vein isolation under uninterrupted oral anticoagulation

Martin Martinek, Elisabeth Sigmund, Christine Lemeš et al. · EP Europace · 2012 · 105 citations · Full text

Clinical Impact of an Open‐Irrigated Radiofrequency Catheter with Direct Force Measurement on Atrial Fibrillation Ablation

Martin Martinek, Christine Lemeš, Elisabeth Sigmund et al. · Pacing and Clinical Electrophysiology · 2012 · 92 citations · Full text

Conduction system pacing, a European survey: insights from clinical practice

Daniel Keene, Frédéric Anselme, Haran Burri et al. · EP Europace · 2023 · 78 citations · Full text